Beyond What Exists - Discovering What’s Possible

Our products focus on current & emerging needs

Better Input. Better Outcomes.

Insight. Effort. Results. These three words summarize Endo Pharmaceuticals. We listen to patients and doctors. We build on what we learn. And we collaborate with our partners to create innovative drugs and delivery systems. Solutions that inspire the medical, economic and practical outcomes we all want. It's this unique combination of forces that drives Endo Pharmaceuticals beyond what exists—to discover what's possible.

Investor Information

ENDP (Common Stock)

NASDAQ GS

Price

$64.66

Change

1.47 (2.33%)

Product Pipeline

Our pipeline of new medicines in development focuses on a broad range of unmet medical needs.

Therapeutic Areas

Pain Management

We believe pain management should be more than a goal. That's why we made it one of our specialties.

Learn More

Urology/Oncology

We focus on two of the most common medical problems facing women and men today: bladder cancer and prostate cancer.

Learn More

Endocrinology

We're dedicated to meeting the needs of children and families affected by central precocious puberty (CPP).

Learn More

Career Opportunities

MA HCP Opt-Out Request Form

Massachusetts prescribers may opt-out of future Endo Pharmaceuticals communications by completing the MA HCP Opt-Out Request Form.

About Endo

Close

Endo International plc is a global specialty healthcare company focused on improving patients' lives while creating value. Endo develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices through its operating companies: AMS, Endo Pharmaceuticals, Paladin Labs and Qualitest.  

Endo has global headquarters in Dublin, Ireland and US headquarters in Malvern, PA. 

Visit Endo.com

Other Companies

AMS

Paladin Labs

Qualitest